68Ga-HER2 Affibody PET/CT Imaging for HER2-Positive Cancer Patients

Clinical trial NCT05535621 · UNKNOWN

Trial details

NCT number: NCT05535621
Sponsor: Tongji Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

HER2-Positive Cancer

Start date: 2021-12-18
Primary completion: 2024-12-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.